in Newswire April 3, 2020

Avet's Metformin Diabetes Drug Found to Contain Probable Carcinogen, Class Action Claims [UPDATE]

by Erin Shaak

Last Updated on October 23, 2020

Hann v. Heritage Pharmaceuticals, Inc.

Filed: March 30, 2020 § 3:20-cv-03415-BRM-LHG

According to a class action, generic metformin manufactured by Heritage Pharmaceuticals has been found to contain dangerously high levels of a probable carcinogen.

Law(s)

State(s)

New Jersey

Case Updates

October 22, 2020 – Another Lawsuit Filed as Metformin Recalls Continue

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on October 23, 2020 — 12:10 PM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.